Can an AI chatbot ease fertility worries for young cancer survivors?

NCT ID NCT07741266

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This pilot trial tests whether a chatbot powered by large language models can help adolescent and young adult cancer survivors address reproductive concerns. Participants will be randomly assigned to use the chatbot or read an electronic brochure with similar information. The study will measure how feasible and acceptable the chatbot is, and whether it improves psychological flexibility, reduces depression, and enhances quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A large language model-driven chatbot called FLORA, which incorporates acceptance and commitment therapy, onco-fertility knowledge, and policy information.
What this could lead to
If effective, this chatbot could offer a scalable, accessible way to support reproductive health and emotional well-being for young cancer survivors, potentially filling gaps in onco-fertility care.
What could go wrong
This is a small pilot study, so results may not be conclusive. The chatbot's effectiveness could vary, and it may not replace personalized medical advice or fully address complex fertility concerns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADOLESCENT AND YOUNG ADULT CANCER SURVIVORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Hong Kong Polytechnic University

    Kowloon, Hong Kong

  • The University of Science and Technology of China

    Hefei, Anhui, 230026, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.